“Connecting Global Buyers with Verified Indian Exporters”

Corn - Based Pharmaceutical Ingredients & Biochemical Manufacturing – Investment Proposal in India

Start a corn-based pharmaceutical ingredients manufacturing plant in India to produce dextrose, sorbitol, maltodextrin, and other API-grade corn derivatives. We offer verified land, industrial support, and machinery setup for launching this high-ROI biochemical unit. Leverage India’s maize production and growing pharma export industry to supply to nutraceutical, injectable, and oral formulation markets worldwide. Ideal for investors targeting API manufacturing, corn derivative businesses, and pharmaceutical raw material exports. Build a future-proof pharma ingredients unit with global compliance and demand.

Investment Opportunity: Bastar, Chhattisgarh, India

Business Overview

We are inviting foreign investors to partner in setting up a pharmaceutical and biochemical manufacturing unit using corn-derived ingredients in Chhattisgarh, India — a region rich in corn production. Corn starch, dextrose, and sorbitol are key ingredients in global pharmaceutical and biotech industries. We offer full local support and land for plant setup, with a flexible partnership model.

Why Corn-Based Ingredients?

Corn starch is a widely used excipient in tablets and capsules.
Dextrose and sorbitol are used in oral and IV formulations.
Biochemicals like lactic acid and maltodextrin are in global demand.
Suitable for pharma, nutraceuticals, medical research, and biotech industries.
Demand for non-synthetic, plant-based inputs is growing rapidly worldwide.
High-value export opportunities.
Growing global demand for natural excipients and biochemicals
India is a global pharma hub – 3rd largest exporter by volume
Corn starch is a safe, biodegradable, non-toxic base for medicines
High-margin industry with long-term demand
Opportunity to serve domestic and export markets
Used in tablets, capsules, glucose, syrups, and drug formulations

Products to Manufacture

Pharmaceutical Grade Corn Starch
Dextrose Monohydrate & Anhydrous
Sorbitol (USP Grade)
Liquid Glucose
Maltodextrin
Lactic Acid
Xylitol
Modified Starches
Biochemical fermentation base (for vaccine, probiotic industries)

Applications

Tablet binding & disintegration
Glucose IV and oral electrolyte products
Sweetening and carrier agents in syrups
Fermentation for vaccine and antibiotic manufacturing
Nutraceuticals, baby food, probiotics

Production Process

Corn starch extraction
Enzymatic hydrolysis
Fermentation (where required)
Filtration & drying
Purification and grading
Packaging (bulk or pharma packs)

Required Certifications

WHO-GMP
ISO 9001 / ISO 22000 / HACCP
FDA (India and optionally US FDA)
FSSAI (for nutrition-grade)
REACH (for EU exports)
Export registration (IEC + DGFT)

Market Scope

Pharmaceutical manufacturers in India & abroad
Export buyers in Europe, US, Japan
Biotech companies
Medical R&D labs and universities
Nutraceutical brands

Business Potential

High-profit margins
Recession-proof and export-ready industry
Scope for long-term contracts with pharma buyers
ROI possible
High-value, low-volume products = easy logistics

Why Chhattisgarh is Ideal for This Plant:

Raw material available in abundance
Tribal maize mills
land and labor cost in Kondagaon region
State support for clean-tech
Access to ports
Environmentally safe location – favorable for bio manufacturing

Our Offer to Investors

Land provided for factory setup
Photos/videos of available land
Assistance in raw material procurement from farmers
Local manpower and operational support
legal setup assistance
Full partnership model available

Investor’s Role & Benefits:

Provide investment in machinery, processing system
Technical know-how
Branding and global sales through export routes
profit margin (retail);(bulk export)
Full JV or long-term lease agreement possible

Contact Us:

📍 Location: Kondagaon, Chhattisgarh, India